Analysis of Chlordecone Tissue Concentrations in Patients Treated for Thyroid Surgery at Guadeloupe University Hospital

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire de la Guadeloupe

About this trial

Chlordecone, an organochlorine pesticide used in the French Caribbean for several decades, is recognized as an endocrine disruptor. Accumulation in thyroid tissue may be modeled using several factors, including blood chlordecone levels, environmental exposure associated with place of residence, and dietary habits.

Eligibility criteria

Qualifiers

adult patients hospitalized at the Guadeloupe University Hospital for surgical treatment of thyroid pathology

person affiliated to or beneficiaries of a social security system

person with free, informed, and written consent signed by the participant and the investigator

Disqualifiers

patients subject to a judicial safeguard measure,

patient under 18 years old

patient without signed consent

current pregnancy at the time of inclusion

Trial design

Treatments tested in this trial

  • Blood and thyroid tissue collection

Treatment groups

69 Participants
are divided into 1 treatment group

Sponsors and collaborators

Centre Hospitalier Universitaire de la Guadeloupe

Lead sponsor

Institut Pasteur de Guadeloupe

Collaborator